?>
Contact us
Follow Us
About Us
Members
Executive Director
Why Biosimilars
Biosimilars 101
Policies
Biosimilars are a Free-Market Solution
The Biosimilar Access and Affordability Act
News
Resources
signalgroup
Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
News
June 22, 2022
signalgroup
The Biosimilars Forum Welcomes Legislation to Hold PBMs Accountable for Unfair Practices
News
June 21, 2022
signalgroup
Rachel Turow Member Spotlight
News
June 16, 2022
signalgroup
Brian Lehman Member Spotlight
News
June 7, 2022
signalgroup
The Biosimilars Forum Commends FTC for Probe into PBMs
News
June 6, 2022
signalgroup
Biosimilars Forum Welcomes Fresenius Kabi
Member Spotlight
May 17, 2022
signalgroup
Tiffany Fletcher Member Spotlight
News
April 6, 2022
signalgroup
Biosimilars Forum Letter to Senate HELP Committee on FDA User Fee Agreements
News
March 31, 2022
signalgroup
HHS Inspector General Report: Biosimilars Could Generate Significant Medicare Part D Savings
News
March 9, 2022
signalgroup
Biosimilars Forum Executive Director to Discuss Current Biosimilars Landscape at World Biosimilars Congress
News
March 2, 2022
signalgroup
The Biosimilars Forum Calls on President Biden to Incentivize Biosimilars to Lower Prescription Drug Costs
Prev page
04
05
06
07
08
Next page